Diagnostic Criteria Controversies

Multiple diagnostic criteria exist for ME/CFS, and the choice of criteria profoundly affects which patients are included in research studies—and therefore what conclusions are drawn about the disease. Oxford criteria (1991): The broadest definition, requiring only unexplained fatigue of \(\geq\) 6 months duration. Does not require PEM. Widely criticized for including patients with primary psychiatric fatigue, idiopathic chronic fatigue, and other conditions that are pathophysiologically distinct from ME/CFS. Studies using Oxford criteria consistently report better outcomes from exercise and psychological therapies—likely because many included patients do not have ME/CFS. Fukuda/CDC criteria (1994): Require \(\geq\) 6 months of unexplained fatigue plus 4 of 8 minor symptoms. PEM is listed as one of 8 optional symptoms rather than a required feature. The Fukuda criteria define a heterogeneous population that includes but is not limited to ME/CFS. Canadian Consensus Criteria (CCC, 2003): Require PEM as a mandatory feature alongside neurocognitive dysfunction, sleep disturbance, and autonomic/neuroendocrine/immune symptoms. The CCC defines a more clinically homogeneous population and is preferred by most ME/CFS researchers and specialist clinicians. International Consensus Criteria (ICC, 2011): The most restrictive criteria, requiring post-exertional neuroimmune exhaustion plus neurological, immune, and energy production impairments. Removes the 6-month waiting period, enabling earlier diagnosis. IOM/SEID criteria (2015): Require substantial reduction in function plus PEM plus unrefreshing sleep, along with cognitive impairment or orthostatic intolerance. Designed for clinical use with minimal burden. The criteria controversy has direct research implications: meta-analyses combining studies using different criteria mix distinct patient populations, diluting effect sizes and obscuring true therapeutic signals. The field is moving toward mandatory use of PEM-requiring criteria (CCC or ICC), but the legacy of Oxford-criteria studies continues to influence clinical guidelines and public perception.